04-Nov-2026 13:30:05

SMS PHARMACEUTICALS Q2 FY27 ; NET PROFIT UP 57% AT ₹40 CR (YOY), UP 91% (QOQ)

REVENUE UP 30% AT ₹316 CR (YOY), UP 53% (QOQ) EBITDA UP 40% AT ₹68 CR (YOY), UP 65% (QOQ) MARGINS AT 21.4% VS 20.0% (YOY), 19.8% (QOQ)

SMS PHARMACEUTICALS LTD.